Research on the molecular mechanism, drug resistance mechanism, and drug resistance reversal mechanism of demethylation drugs in the treatment of p53 mutant myeloid leukemia; In addition, panoramic identification of p53 mutations selected during iPSC formation and drug de selection studies were conducted